Background: Coronary evaginations can occur after implantation of bioresorbable vascular scaffolds (BRS) and may be associated with scaffold thrombosis. Aim of this study was to clarify the clinical manifestation, extent and time course of coronary artery remodeling in vessel segments that develop angiographically detectable evaginations following BRS implantation through optical coherence tomography (OCT) analysis.

Methods: In 8 patients, 10 BRS (Absorb, Abbott Vascular, Santa Clara, CA, USA) which displayed coronary evaginations in clinically driven late invasive coronary angiograms were identified and findings were compared to 10 BRS in 8 patients without coronary evaginations. Vessel and device geometry was analyzed in serial OCT cross-sections at a spacing of 200 μm. Measured BRS dimensions were normalized to the reference vessel size at implantation.

Results: In OCT, major evaginations on average affected 24 ± 19% of the scaffold length. Scaffolds with major evaginations had a significantly larger lumen area than scaffolds without evaginations (mean normalized lumen area 1.19 ± 0.58 vs. 0.77 ± 0.38; p < 0.001), and also displayed a significantly larger scaffold area (mean normalized scaffold area: 1.36 ± 0.6 vs. 1.13 ± 0.43; p < 0.001), and scaffold diameter (mean normalized scaffold diameter: 1.17 ± 0.33 vs.1.04 ± 0.19; p < 0.001). Lumen area (r = 0.47; p < 0.001), scaffold area (r = 0.52; p < 0.001), and scaffold diameter (r = 0.74; p < 0.001) in the evagination group were positively correlated to the time since scaffold implantation.

Conclusion: Coronary evaginations following BRS implantation are associated with an increased scaffold area, indicating that the scaffold follows the outward remodeling of the artery. The process affects the entire scaffold length and seems to be continuously progressing following implantation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.08.001DOI Listing

Publication Analysis

Top Keywords

coronary evaginations
16
evaginations
8
implantation bioresorbable
8
bioresorbable vascular
8
vascular scaffolds
8
major evaginations
8
lumen area
8
coronary
5
brs
5
major coronary
4

Similar Publications

Background: Although very late stent thrombosis (VLST) remains an important concern, the underlying etiology and clinical characteristics are not fully elucidated in Japanese patients who undergo intravascular imaging-guided percutaneous coronary intervention (PCI) regularly.

Methods: We identified 50 VLST lesions (bare-metal stent [BMS] [n = 16], first-generation drug-eluting stent [DES] [n = 14] and newer-generation DES [n = 20]) in patients managed in our institutes. The underlying mechanism of VLST was assessed by optical coherence tomography (OCT), and the major etiology of each lesion was determined.

View Article and Find Full Text PDF

Intracoronary imaging (ICI) modalities, namely intravascular ultrasound (IVUS) and optical coherence tomography (OCT), have shown to be able to reduce major adverse cardiovascular events in patients undergoing percutaneous coronary intervention (PCI). Nevertheless, patients with ST-segment elevation myocardial infarction (STEMI) have been practically excluded from contemporary large randomized controlled trials. The available data are limited and derive mostly from observational studies.

View Article and Find Full Text PDF

Background: Since their emergence, drug-coated balloons (DCBs) have been used widely to treat in-stent lesions with coronary artery disease (CAD). However, despite their superior efficacy to balloon angioplasty, how DCBs affect neointimal characteristics is poorly understood.

Objectives: We aimed to assess the neointimal characteristic changes following DCB treatment.

View Article and Find Full Text PDF

Incidence and natural history of coronary evagination after implanted biodegradable polymer sirolimus-eluting stent.

Eur Heart J Open

January 2022

Division of Cardiology, Department of Internal Medicine, Iwate Medical University, 2-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3695, Japan.

Article Synopsis
  • The study evaluates the occurrence and progression of coronary evagination (CE) after using biodegradable polymer sirolimus-eluting stents (BP-SES), an area not previously explored.
  • The research involved serial imaging to monitor stable coronary lesions treated by BP-SES, finding that CE appeared in 42.6% of lesions at 1 month but decreased to 24.5% by 3 months, mostly resolving by 12 months.
  • The results indicate that while CE can arise shortly after stent implantation, it typically resolves without complications, supporting the safety of BP-SES in clinical use.
View Article and Find Full Text PDF

Objectives: Drug-coated balloons (DCBs) have theoretical advantages over drug-eluting stents (DESs) to facilitate stent healing. We studied whether, in patients undergoing primary coronary interventions (pPCIs), a strategy of DCB after bare-metal stent improves early healing as determined by optical coherence tomography (OCT) compared with new-generation DES.

Methods: pPCI patients were randomized (1:1) to treatment with new-generation sirolimus-eluting stents (DES group) or DCB-strategy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!